Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Atenolol in hypertension: is it a wise choice?
Carlberg B, Samuelsson O, Lindholm LH. Carlberg B, et al. Lancet. 2004 Nov 6-12;364(9446):1684-9. doi: 10.1016/S0140-6736(04)17355-8. Lancet. 2004. PMID: 15530629
Factors influencing admission blood pressure levels in patients with acute stroke.
Carlberg B, Asplund K, Hägg E. Carlberg B, et al. Stroke. 1991 Apr;22(4):527-30. doi: 10.1161/01.str.22.4.527. Stroke. 1991. PMID: 2024282
The prognostic value of admission blood pressure in patients with acute stroke.
Carlberg B, Asplund K, Hägg E. Carlberg B, et al. Stroke. 1993 Sep;24(9):1372-5. doi: 10.1161/01.str.24.9.1372. Stroke. 1993. PMID: 8362433
Magnesium therapy in type 1 diabetes. A double blind study concerning the effects on kidney function and serum lipid levels.
Hägg E, Carlberg BC, Hillörn VS, Villumsen J. Hägg E, et al. Among authors: carlberg bc. Magnes Res. 1999 Jun;12(2):123-30. Magnes Res. 1999. PMID: 10423707 Clinical Trial.
Evaluation of a computer-based decision support system for treatment of hypertension with drugs: retrospective, nonintervention testing of cost and guideline adherence.
Persson M, Mjörndal T, Carlberg B, Bohlin J, Lindholm LH. Persson M, et al. Among authors: carlberg b. J Intern Med. 2000 Jan;247(1):87-93. doi: 10.1046/j.1365-2796.2000.00581.x. J Intern Med. 2000. PMID: 10672135
1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden.
Persson M, Carlberg B, Mjörndal T, Asplund K, Bohlin J, Lindholm L; 1999 WHO/ISH Hypertension Guidelines. Persson M, et al. Among authors: carlberg b. J Hypertens. 2002 Jan;20(1):29-35. doi: 10.1097/00004872-200201000-00006. J Hypertens. 2002. PMID: 11791023 Clinical Trial.
Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample.
Persson M, Carlberg B, Weinehall L, Nilsson L, Stegmayr B, Lindholm LH. Persson M, et al. Among authors: carlberg b. J Hypertens. 2003 Jun;21(6):1089-95. doi: 10.1097/00004872-200306000-00008. J Hypertens. 2003. PMID: 12777945
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O. Lindholm LH, et al. Among authors: carlberg b. J Hypertens. 2003 Aug;21(8):1563-74. doi: 10.1097/01.hjh.0000084723.53355.76. J Hypertens. 2003. PMID: 12872052 Clinical Trial.
Both the low-density lipoprotein/high-density lipoprotein and the apolipoprotein B/apolipoprotein A-I ratios increased in the hydrochlorothiazide group. ...
Both the low-density lipoprotein/high-density lipoprotein and the apolipoprotein B/apolipoprotein A-I ratios increased in the hydroch …
Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy.
Persson M, Carlberg B, Tavelin B, Lindholm LH. Persson M, et al. Among authors: carlberg b. J Hypertens. 2004 Jan;22(1):65-71. doi: 10.1097/00004872-200401000-00014. J Hypertens. 2004. PMID: 15106796 Clinical Trial.
[Does Kent Forsen possibly have a complete picture about atenolol?].
Carlberg B, Samuelsson O, Lindholm LH. Carlberg B, et al. Lakartidningen. 2005 Jan 17-23;102(3):151-2. Lakartidningen. 2005. PMID: 15712744 Swedish. No abstract available.
106 results
Jump to page
Feedback